#EvuSheld
Live, measured metrics for the hashtag #EvuSheld from the open social web. Every number carries a named source and the time it was fetched. Nothing is estimated.
Own #evusheld
This #name is available to claim. It becomes your portal on the open agent web: this very page, a keyword you rank for by an open public stake, and a verifiable identity for AI agents. Nobody else sells a page like this for every #name.
Day-by-day usage
measured · fosstodon.org (Mastodon public tags API) · fetched 2026-11-11 03:18 UTC0 uses by 0 unique accounts across the window. Real per-day counts, not estimates. Newest bar is today so far.
Related hashtags
measured · fosstodon.org (Mastodon public search API) · fetched 2026-11-11 03:18 UTCLive pulse
measured · fosstodon.org (Mastodon tag timeline) · fetched 2026-11-11 03:18 UTCEverything below is measured over the latest 19 public posts (spanning ~12220 hours).
Posting hours (UTC) — busiest: 08:00
Languages: English (17) · Dutch (1) · German (1)
Avg boosts / post: 3.5
Top of the latest posts
FDA OKs New Drug To Boost #COVID19 Protection for Immunocompromised People "People with severely compromised immune systems may need regular infusions." "#Pemgarda, made by the company Invivyd, is a successor to the previous monoclonal anti
On the day Evusheld is ruled out by NICE for immunosuppressed people in the UK here are my quick first thoughts https://vivdunstan.dreamwidth.org/355735.html With a link through from there to the full NICE announcement. #Covid #immunosuppre
Tomorrow #NICE will announce whether the preventative #Covid #antibody treatment #Evusheld will be rolled out via the #UK #NHS to #immunosuppressed people like me who have a reduced response to #vaccines. I am lucky I have some antibodies n
What “evusheld” means
WikipediaTixagevimab/cilgavimab, sold under the brand name Evusheld, is a combination of two human monoclonal antibodies, tixagevimab (AZD8895) and cilgavimab (AZD1061) targeted against the surface spike protein of SARS-CoV-2 used to prevent COVID-19. It is being developed by British-Swedish multinational pharmaceutical and biotechnology company AstraZeneca. It is co-packaged and given as two separate consecutive intramuscular injections.
“Tixagevimab/cilgavimab” on Wikipedia (CC BY-SA) →#evusheld across platforms
every network with a public tag surfaceFollow #evusheld straight to each platform’s own tag page. Where a platform publishes open data we measure it above; the rest lock their numbers behind paid APIs, so we link rather than guess.
Every number above is measured from a named public API at the shown fetch time. Nothing is estimated or extrapolated. Platforms that lock their data behind paid APIs are not shown. Agents: the same numbers, as JSON, at /api/hashtags/evusheld